Searched for
REGULATORY OVERSIGHT ON DRUGS
Coal minister flags unregulated expansion of online pharmaciesUnion minister G Kishan Reddy has written to the health minister about concerns over online pharmacies. These platforms are accused of deep...
Experts back OTC access to NRT across all formats and dosages, including 2 mg and 4 mg, as India struggles with a Tobacco quit success rate under 5%The report highlights the significant economic burden of tobacco use, particularly among low-income households, and underscores how reducin...
Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...
Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
Drugmaker Granules to tighten oversight after US FDA warning, executive saysThe company, which is globally one of the largest paracetamol makers and a major player in the active pharmaceutical ingredients market, de...
Indian drugmaker Granules to tighten oversight after US FDA warning, exec saysAmid growing scrutiny from the U.S. FDA over documentation practices and contamination issues, Granules India is reinforcing its manufactur...
Centre to soon set up a digital portal to track narcotic drugsThe proposed platform will enable real-time, end-to-end digital tracking of all regulated pharmaceutical products, covering every stage fro...
Easy access to weight-loss drugs rings alarm bells among doctors, authorities; regulators step inWeight-loss drugs are being sold without prescriptions in India. This is causing alarm among doctors and authorities. People are buying the...
Govt orders safety review of popular weight-loss drugs amid rising demandIndian authorities are increasing vigilance on popular weight loss drugs. Indian Pharmacopoeia Commission will now compile reports on adver...
Trump administration to rejoin offshore drilling agencies separated after 2010 Gulf oil spillThe Trump administration is merging two agencies that were split after the 2010 Gulf oil spill. This move aims to boost efficiency and expe...
CCTV in medical stores may become mandatory; DCC proposes rule changeMedical stores will soon be required to install CCTV cameras. This new rule aims to ensure every sale is clearly recorded. The Drug Consult...
GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...
Centre steps up oversight on GLP-1 drugs amid concerns over 'improper' practicesIndia's drug regulator is increasing oversight of GLP-1 weight loss drugs. Inspections across 49 entities revealed violations like unauthor...
Union Budget 2026: Govt to overhaul drug regulator CDSCO, announces Rs 10,000 crore ‘Biopharma Shakti’ pushIndia Budget 2026: India's drug regulatory authority, CDSCO, will be strengthened to meet global standards and speed up approvals. A new in...
Quality issues: Regulator looks to tighten marketing & sale of drugsIndia's drug regulator plans new rules for medicine marketers. Companies will need a license to sell and distribute drugs. This aims to imp...
Check health vitals: The complexities of medical regulationsThe recent string of unfortunate events brings to light severe shortcomings within India's health sector regulations. The deaths linked to ...
One nation, one check: India needs centralised drug regulation to ensure public healthCentralisation of drug regulation in India is critical to ensure consistent drug quality and safety standards nationwide. The current fragm...
Quality of pharma must not be strainedNews that 48 common drugs manufactured in India failed to meet quality standards comes as little surprise. The absence of a robust drug reg...
The Department of Pharmaceuticals proposes to oversee drug regulatorThe Cabinet secretary had constituted a committee tasked with reforming the drug regulatory system under the chairmanship of Rajesh Bhushan...
Five ways pharmaceutical and healthcare sectors can be ‘Modified’The government has targeted to increase GDP expenditure on healthcare to 2.5 per cent by 2025.